Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 3
2012 1
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli.
Gwon HJ, Yoshioka H, Song NE, Kim JH, Song YR, Jeong DY, Baik SH. Gwon HJ, et al. Among authors: yoshioka h. Prep Biochem Biotechnol. 2012;42(2):143-54. doi: 10.1080/10826068.2011.583975. Prep Biochem Biotechnol. 2012. PMID: 22394063
Enhanced synthesis of L-threo-3,4-dihydroxyphenylserine by high-density whole-cell biocatalyst of recombinant L-threonine aldolase from Streptomyces avelmitilis.
Baik SH, Yoshioka H. Baik SH, et al. Among authors: yoshioka h. Biotechnol Lett. 2009 Mar;31(3):443-8. doi: 10.1007/s10529-008-9885-0. Epub 2008 Nov 28. Biotechnol Lett. 2009. PMID: 19039530
Global Comparison of Changes in the Number of Test-Positive Cases and Deaths by Coronavirus Infection (COVID-19) in the World.
Hisaka A, Yoshioka H, Hatakeyama H, Sato H, Onouchi Y, Anzai N. Hisaka A, et al. Among authors: yoshioka h. J Clin Med. 2020 Jun 18;9(6):1904. doi: 10.3390/jcm9061904. J Clin Med. 2020. PMID: 32570833 Free PMC article.
Synthesis of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) with thermostabilized low-specific L-threonine aldolase from Streptomyces coelicolor A3(2).
Balk SH, Yoshioka H, Yukawa H, Harayama S. Balk SH, et al. Among authors: yoshioka h. J Microbiol Biotechnol. 2007 May;17(5):721-7. J Microbiol Biotechnol. 2007. PMID: 18051291 Free article.
[Study on the diagnostic role of NT-proBNP assay for assessment of cardiac function, and the effect of renal function--comparable study with BNP].
Ookura H, Ito H, Yoshioka H, Suzuki R, Yoshika M, Takahashi H. Ookura H, et al. Among authors: yoshioka h. Rinsho Byori. 2010 Feb;58(2):139-47. Rinsho Byori. 2010. PMID: 20229812 Japanese.
Determinants of carotid atherosclerosis in the general Mongolian population.
Uurtuya S, Kotani K, Yoshioka H, Yamada T, Taniguchi N. Uurtuya S, et al. Among authors: yoshioka h. Ethn Dis. 2010 Summer;20(3):257-60. Ethn Dis. 2010. PMID: 20828099
Comparative study of atherosclerotic parameters in Mongolian and Japanese patients with hypertension and diabetes mellitus.
Uurtuya S, Kotani K, Taniguchi N, Yoshioka H, Kario K, Ishibashi S, Yamada T, Kawano M, Khurelbaatar N, Itoh K, Lkhagvasuren T. Uurtuya S, et al. Among authors: yoshioka h. J Atheroscler Thromb. 2010 Feb 26;17(2):181-8. doi: 10.5551/jat.1354. Epub 2010 Feb 3. J Atheroscler Thromb. 2010. PMID: 20124737 Free article.
[A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
Terakura M, Kaneko M, Ikebe T, Yoshioka H, Tanaka H. Terakura M, et al. Among authors: yoshioka h. Gan To Kagaku Ryoho. 2008 Apr;35(4):645-7. Gan To Kagaku Ryoho. 2008. PMID: 18408436 Japanese.
Feedback